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Background: Age has been shown to be related with increased vascular stiffness, cardiac structural alter-
ations, and geometric remodeling. Data regarding the relationship between clinical heart failure (HF)
symptoms and aging-related alterations of ventricular geometries are scarce.We therefore investigated this
issue.
Methods: We subsequently studied 1,577 participants without cardiovascular or chronic lung disorders.
Echocardiography-deﬁned cardiac structures and left ventricular (LV) geometries, including LV mass,
relative wall thickness, and mass-to-volume ratio were all determined. Baseline clinical variables,
medical histories, and functional impairment in terms of HF symptoms during exercise were all obtained.
Multivariate bootstrapping derived odds ratio from various models were used to represent the inde-
pendent predictors for HF.
Results: Of all, 1,459 participants (age: 49.3 10.8; 36% female) with normal ejection fraction (66.8 4.7%)
were enrolled in our study. Cardiac structural alterations, ventricular geometric remodeling, and diastolic
dysfunction were signiﬁcantly related to aging process, along with increasing cardiovascular morbidities
and risk factors. After adjusting for confounders and LVmass, change in ventricular geometries in terms of
mass-to-volume ratio remained an independent risk, whereas relative wall thickness had a borderline
signiﬁcance for HF symptoms (odds ratio: 2.79 and 1.04, p¼ 0.047 and 0.08, respectively).
Conclusion: Cardiac structure, function, and various ventricular remodeling patterns were age-related.
Such remodeling process is not only associated with a higher incidence of cardiovascular morbidities but
also more likely to develop HF symptoms, which are independent of clinical variables and LV mass.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Heart failure (HF) with relatively preserved ejection fraction
(HFpEF) actually comprised nearly one-half of all HF patients and
have been shown to be associated with grave prognosis1e3.
Although advances in the current medical therapies and efforts
have been made, the improvement of clinical outcomes of HFpEF
remains limited, partially because of limited understanding of the
underlying mechanisms and the heterogenecity in such patientof Cardiology, Department of
tion 2, Chung-Shan North Rd,
g).
erest.
iwan Society of Geriatric Emergenpopulation4e7. Previous studies indicated that diastolic dysfunc-
tion5,6 secondary to myocardial damage and cardiac chamber
stiffness7 or presence of ventricular-vascular uncoupling may play
a role. In addition, there is accumulating data suggesting that
HFpEF predominantly affects the elderly and those with hyper-
tension (HTN)1,3,8. Conventional hypothesis focusing on the natural
pathways of the continuum from HTN, hypertrophy to HF has long
been accepted from both animal9 and human studies10. Further-
more, models with respect to the presence of HTN accompanied by
aging process leading to geometric alteration, ventricular stiffness,
and HF symptoms development have been well described4,6,7. As
a minor form of hypertrophy, phenotype left ventricular (LV)
concentric remodeling has also been recognized to be related to
worse cardiovascular prognosis in some studies11e15.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C.-L. Hung et al.18Biological aging per se, when accompanied by several factors,may
be important in this remodeling geometry4,7,12,16. Although models
established for suchrelationshipmaybecomplicatedbyother factors,
such as comorbidities and confounders, phenotypic ventricular
remodelinghasbeenobserved to conferhigher risk forcardiovascular
events5,6,12e15. Moreover, myocardial dysfunctionwith aging process
at cellularormolecular levels inminor geometrical alterationhas also
beenwell described17,18. Such ventricular remodeling process, when
deﬁned by traditional methods, mainly focuses on alterations in
ventricular mass8,19 or less commonly, in relative wall thickness
(RWT) and mass-to-volume ratio13,15,16. However, clinical data using
alternative descriptions and its relationshipwith aging and incidence
of exercise intolerance are lacking.We thus sought to investigate this
remodeling process with aging by using various methods and relate
such ventricular alterations to clinical HF symptoms.
2. Materials and Methods
2.1. Study participants enrollment
We consecutively enrolled 1,577 participants without known
cardiovascular diseases who attended cardiovascular health survey
from outpatient clinics or from health evaluation from January 2004
to December 2007. Thorough review of baseline characters, medical
history, physical examination, smoking, and physical activity status
wereall performedbystructuredquestionnaireswithcardiovascular
diseases deﬁned as previousmyocardial infarction, coronary arterial
disease, stroke, prior hospitalization for HF, and peripheral arterial
disease. Complete electrocardiogram (ECG) from 12 leads and chest
X-radiography (CxR) were done for all participants. Myocardial
ischemia pattern by ECG was deﬁned as ﬂat or downsloping ST
segment depression without obvious ventricular hypertrophy. All
baseline characteristics and anthropometric measures, including
age, body height, body weight, and body mass index (BMI) were all
collected. Cuff-deﬁned resting blood pressures were measured by
using standardized sphygmomanometer performed bymedical staff
blinded to the other test results. Subjectswith known cardiovascular
diseases as previously described, previous pacemaker implantation,
presence of pulmonary diseases (such as chronic obstructive
pulmonary disease, bronchitis, or asthma), previous cardiac surgery,
or overt renal insufﬁciency (creatinine> 2.5 mg/dL) were all
excluded in our study. Fasting plasma glucose and other laboratory
data, including lipid proﬁles, renal function, and serum albumin and
uric acid levels were obtained by a Hitachi 7170 Automatic Analyzer
(Hitachi Corp., Hitachinaka Ibaraki, Japan) from venous sampling.
The history of diabetes mellitus (DM) was deﬁned as fasting glucose
level higher than 126 mg/dL or any current diabetic medication for
treating a previously diagnosed DM. The history of HTNwas deﬁned
as systolic blood pressure higher than 140 mmHg, diastolic blood
pressure higher than 90 mmHg, or previously diagnosed HTN with
current medication. Regular exercise was deﬁned as regular partic-
ipationof at leastmoderate degree intensityof physical activity for at
leasthalf anhouronaverageperday. Subjectswithsigniﬁcantdegree
of functional impairment (corresponding to functional Class II or III
as deﬁned by the Goldman’s speciﬁc activity scale) presented with
exertional dyspnea symptoms by self-report, structural question-
nairewith objective scores were diagnosed as HF in our study20. The
design of this study was approved by the local ethics committee in
accordance with the Declaration of Helsinki.
2.2. Deﬁnition of cardiac structures, LV geometries, diastology,
and LV mass quantiﬁcation
Transthoracic echocardiography was performed by a single
experienced technician blinded to other study results by usingHewlett Packard instrument (Sonos 5500, Philips, The Netherlands)
equipped with a 2.5e4.5 MHz transducer. All echocardiographic
measures represented the average value of successive three heart
cycles. Parameters of ascending aortic diameter, aortic valve
separation distance, left atrium, right ventricle internal diameter
quantiﬁcation, end-diastolic volume (EDV), and end-systolic
volume (ESV), LV ejection fraction (LVEF) by the modiﬁed Teichholz
method with subsequent LV mass (gram) determination from
M-mode were all measured according to the criteria of American
Society of Echocardiography21. LV mass index (gram/square meter)
was deﬁned as the ratio of LV mass to body surface area. Wall
thickness and dimensions of LV were collected. Patterns of LV
geometry, including RWT, calculated as the ratio of summation
from both end-diastolic LV interventricular septal wall and poste-
rior wall thickness to end-diastolic LV internal diameter, withmass-
to-volume ratio deﬁned as LV mass divided by LV EDV. All these
parameters were assessed by M-mode from parasternal long-axis
view. LV concentric geometry was deﬁned as those with RWT
greater than 0.42. Diastolic functional evaluation by using pulsed-
wave Doppler sampling positioned at mitral leaﬂets tip area with
early (E) and late diastolic (A) ﬁlling velocities ratio (E/A ratio) were
deﬁned, and that pulmonary vein Doppler pattern with systolic (S)
and diastolic (D) ratio determined by sampling positioned 0.5 cm
into pulmonary vein area were also obtained from LV apical
4-chamber view with adequate settings. Exaggerated E/A ratio
was deﬁned as E/A more than 2.5 and reversed E/A was deﬁned
as E/A less than 1.0. Prolonged deceleration time (DT) of E was
deﬁned as DT larger than 260 ms. Patterns of diastolic dysfunc-
tion are those deﬁned either as impaired ventricular relaxation
(deﬁned as prolonged DT of E with reverse E/A ratio) or impaired
ventricular compliance (deﬁned as exaggerated E/A ratio with
S/D reversed pattern in the middle and aged population). LV
mass index greater than 95 g in women and greater than 115 g in
men were further deﬁned as LV hypertrophy (LVH) as previous
literature2. Participants with at least moderate degree valvular
heart disease or any degree of valvular stenosis, pulmonary HTN
(systolic pulmonary arterial pressure more than 60 mmHg),
existence of congenital heart diseases, or LVEF less than 50%
were excluded in this study. In addition, participants with CxR
demonstrating minor calciﬁcation in heart or aortic structure
were deﬁned as atherosclerotic, and increased CT ratio were
further deﬁned as a cardiac-to-thoracic ratio greater than 0.5.
2.3. Statistical analysis
Continuous data were presented as mean standard deviation
andwere comparedwith nonparametric trend test (Wilcoxon-Rank
sum test) across ordered age groups with categorical or propor-
tional incidence data expressed as proportion and compared by Chi
square or Fisher Exact test as appropriate. The odds ratio (OR) of
individual clinical variable and ventricular geometric parameters
on the impact of HF symptoms in our study was calculated by
univariate and multivariate bootstrapping method. Bootstrapping
of repetition for 1,000 times of resampling the original data set was
adopted in testing the reliability of the data set by creating
randomly generated pseudoreplicate data sets from the original
matrix. Some new matrices were then created as the same size as
the original one. The frequency of a branch found was recorded as
the bootstrap proportion. These proportions estimated can thus be
represented as a measure of the reliability of individual branches in
the optimal tree.
All data were analyzed with the software STATA 9.0 package
(Stata Corp., College Station, TX, USA). The p value was set at two-
tailed probability and a p value less than 0.05 was considered
statistically signiﬁcant.
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3.1. Baseline demographics, characteristics, and medical
information
Table 1 lists the baseline demographics, serum biochemistries,
andmedical histories of the enrolled participants in our study. Of all
1,577 participants initially enrolled, 1,459 fulﬁlled ﬁnal enrollment
criteria for data analysis. With increasing age, there was decreasing
body height and weight, whereas increasing BMI, circumferential
waist, and waist-to-hip ratio (all p< 0.001). Systolic blood pressure
was observed to parallel the diastolic blood pressure although heart
rate tends to decrease with age (all p< 0.001). Serum albumin level
was observed to decrease (p< 0.001). Except for high-density
lipoprotein levels, there was a worse trend toward metabolic
abnormalities, including higher fasting glucose, cholesterol,
triglyceride, and low-density lipoprotein levels across the older
groups (all p< 0.001). Blood urea nitrogenwas also observed to rise
up (p< 0.001), although renal function did not show much differ-
ence in terms of creatinine level (p¼ 0.85).
Higher prevalence of HTN as well as DM and stroke history was
associated with aging but a reversed chance of smoking behavior
was observed (all p< 0.001). Finally, the aging population were
more likely to have regular exercise in our cohort (p< 0.001).
3.2. Age-related cardiac structural alterations, diastolic
dysfunction, and geometric remodeling
We further listed the parameters of cardiac structures and
associated ventricular geometric remodeling across different age
groups in Table 2. In our cohort, we observed a relatively lowTable 1
Baseline demographics, characteristics, and medical information of enrolled participants
Baseline demographics, characteristics, and medical information
Age groups <30 (N¼ 54) 30e40 (N¼ 193) 40e5
Baseline demographics
Age, yr 25.8 3.0 35.2 2.9 45.1
Height, cm 168.6 7.7 168.4 8.2 166
Weight, kg 69.5 19.9 67.6 13.5 66.8
BMI, kg/m2 24.2 5.9 23.7 3.9 24.1
Waist, cm 80.7 15 80.4 11 81.8
Waist-hip ratio 0.84 0.08 0.86 0.07 0.88
Waist-BMI ratio 3.39 0.3 3.42 0.26 3.41
SBP (mmHg) 114.7 15.6 116.2 15.7 116.8
DBP (mmHg) 71.1 10.1 74.1 11.1 75
HR (beats/min) 75 9.5 75.5 11.2 75
Serum biochemistry
Albumin, g/dL 4.6 0.3 4.6 0.3 4.4
AC sugar, mg/dL 88.6 7.2 94 16 98.2
BUN, mg/dL 9.8 2.6 11 3.1 11.6
Creatinine, mg/dL 0.9 0.16 0.92 0.18 0.92
Uric Acid, mg/dL 5.9 1.6 6.2 1.6 5.8
Cholesterol, mg/dL 177.6 35.3 189.5 41 194
TG, mg/dL 95 65.5 137.2 166.3 138.8
HDL, mg/dL 57.9 15.7 54 14.3 53.9
LDL, mg/dL 110.7 34.4 121.3 29.7 125.9
Medical history, N (%)
HTN Hx 3 (6) 14 (7) 51 (1
DM Hx 0 (0) 2 (1) 19 (4
Stroke Hx 0 (0) 0 (0) 0 (0)
Smoking 15 (28) 40 (21) 118
Drinking 14 (26) 37 (20) 104
Exercise 12 (22) 31 (16) 139
AC sugar¼ fasting glucose level; BMI¼ body mass index; BUN¼ blood urea nitrogen
high-density lipoprotein; HR¼ heart rate; HTN Hx¼ history of hypertension; LDL¼ low-incidence of concentric LVH (4.1%) with 3.4% eccentric LVH, 18.7%
concentric remodeling, and 73.8% normal LV geometry, respectively.
We also observed that ascending aortic diameter, aortic root
dimension, and left atrium and right ventricular internal diameter
all seemed to increase with aging (all p< 0.001). Similarly, as
a whole group, both LV septal and posterior wall increased
(p< 0.001), whereas there were no signiﬁcant differences in
ventricular end-diastolic and end-systolic internal diameter
(p¼ 0.52 and 0.49, respectively) or volume (p¼ 0.72 and 0.51,
respectively) leading to a more concentricity phenotype with
increased RWT (p< 0.001) by age. In the female subgroup (Fig. 1),
however, the trend of increasing EDV and ESV across the ordered
age groups showed signiﬁcance (p¼ 0.002 for EDV and p¼ 0.028
for ESV, respectively). There was also an observed higher incidence
of aortic and mitral valve calciﬁcation in the elderly group
(p< 0.001) as well as a higher prevalence of impaired diastolic
pattern (p< 0.001). Moreover, LV mass, mass indexed to body
surface area, and mass-to-volume ratio all rise up in the aging
population (all p< 0.001) (Fig. 2). Amarginal trend of higher EF was
observed with aging (p¼ 0.04). In Fig. 3, we also showed the
prevalence of diastolic dysfunction based on different geometric
remodeling quartile groups related to gender differences. Gener-
ally, the prevalence of diastolic dysfunction was higher in the
female population and that both genders demonstrated signiﬁcant
trends toward higher incidence of such abnormality across
different worsening geometric quartiles (all p< 0.001).
ECG showed a higher rate of myocardial ischemia pattern across
the different groups (p< 0.001), although the pattern of LVH was
not so obvious (p¼ 0.42). CxR also showed higher incidence of
atherosclerotic changes and pattern of cardiomegaly or hyperten-
sive cardiovascular disease with aging (all p< 0.001).0 (N¼ 492) 50e60 (N¼ 519) 60 (N¼ 201) p
 2.8 54.1 2.8 67.1 5.7 <0.001
7.7 162.9 8.3 159.7 8.4 <0.001
 12.1 65.3 11 63.1 11.4 <0.001
 3.5 24.5 3.1 24.7 3.7 <0.001
 9.4 83.2 9.5 85 10.1 <0.001
 0.07 0.89 0.07 0.92 0.08 <0.001
 0.28 3.41 0.27 3.48 0.31 <0.001
 14.6 122.7 16.2 132 17.6 <0.001
10.7 76.8 10.3 76 9.5 <0.001
9.8 74.4 9.6 73.7 10.2 <0.001
0.2 4.4 0.2 4.3 0.3 <0.001
 22.2 102.3 23.9 108.5 31.6 <0.001
 3.4 12.1 3.9 13.8 5.8 <0.001
 0.21 0.9 0.23 0.97 0.3 0.85
1.5 5.8 1.4 6.1 1.5 0.64
32.5 203.9 34.9 202.8 40.1 <0.001
 121.8 136.7 87.8 134.7 81.8 <0.001
 15.1 55.2 16.1 54.8 15.7 0.1
 30.3 135.2 31.5 132.3 37.5 <0.001
0) 95 (18) 78 (39) <0.001
) 36 (7) 34 (17) <0.001
4 (1) 6 (3) <0.001
(25) 96 (19) 35 (18) <0.001
(22) 140 (30) 42 (23) 0.157
(29) 223 (44) 94 (48) <0.001
; DBP¼ diastolic blood pressure; DM Hx¼ history of diabetes mellitus; HDL¼
density lipoprotein; SBP¼ systolic blood pressure; TG¼ triglyceride.
Table 2
Parameters of age-related cardiac structural alterations, diastolic dysfunction, and geometric remodeling
Parameters of cardiac structural alterations, diastolic dysfunction, and geometric remodeling
Age groups <30 (N¼ 54) 30e40 (N¼ 193) 40e50 (N¼ 492) 50e60 (N¼ 519) 60 (N¼ 201) p
AO (mm) 29.9 3.7 31 3.6 32 3.9 31.8 4 32.5 3.9 <0.001
AV (mm) 20.6 2.1 20.6 2.2 20.7 2.4 20 2.2 19.5 2.1 <0.001
RV (mm) 13.2 4 14 3.7 14.5 3.7 14.3 3.8 15 3.9 <0.001
LA (mm) 30.6 5.1 30.7 4.5 31.9 4.7 32.7 4.2 33.9 4.9 <0.001
IVS (mm) 8.5 1.1 8.9 1.4 9.2 1.5 9.5 1.6 10.0 1.7 <0.001
LVPW (mm) 8.2 1.3 8.7 1.3 8.9 1.4 9.0 1.4 9.6 1.5 <0.001
LVIDd (mm) 46.5 3.9 46.8 3.8 47 3.8 46.6 3.8 46.9 4 0.52
LVIDs (mm) 29.6 3.0 29.5 3.0 29.3 3 29.2 2.9 29.6 3.2 0.49
LVEDV (mL) 102.6 22.2 102 19.1 103.1 19.3 101.8 19.6 101.5 20.1 0.72
LVESV (mL) 34.2 9.1 34.4 8.9 34.3 8.4 33.5 8.5 34.1 8 0.51
RWT (%) 35.9 4.3 38.3 5 39.1 5.5 40.3 6.3 42.7 6.8 <0.001
LVEF (%) 65.9 4.1 66.5 4.8 66.8 4.7 67.1 4.7 66.9 5.0 0.04
SV (mL) 66.1 13.5 68 12.7 68.2 13.2 68.2 13.5 68.5 14.0 0.22
AoV MV calciﬁcation (%) 0 (0) 0 (0) 1 (0.2) 16 (3) 26 (13) <0.001
Impaired diastolic pattern 0 (0) 5 (3) 39 (8) 98 (19) 117 (58) <0.001
LV mass (gm) 131.3 37.5 141.9 37.8 147.7 38.2 150.7 37.9 161.9 40.7 <0.001
LV mass index (g/m2) 67.5 12.6 73.9 14.7 78 16.1 81.4 17 90.2 19.6 <0.001
Mass-to-volume ratio (g/mL) 1.27 0.20 1.39 0.24 1.43 0.25 1.49 0.29 1.61 0.31 <0.001
LVH-ECG (%) 1 (2) 5 (3) 25 (5) 27 (5) 9 (5) 0.42
Ischemia ECG (%) 0 (0) 3 (2) 11 (2) 19 (4) 13 (7) <0.001
Atherosclerotic CxR (%) 0 (0) 0 (0) 10 (2) 41 (8) 50 (25) <0.001
Cardiomegaly HCVD CxR (%) 0 (0) 2 (1) 22 (5) 44 (9) 38 (19) <0.001
AO¼ ascending aortic diameter; AV¼ aortic valve separation distance; AoV MV¼ aortic/mitral valve; CxR¼ chest X-radiography; ECG¼ electrocardiography; HCVD¼ hy-
pertensive cardiovascular disease; IVS¼ interventricular septal wall thickness; LA¼ left atrium diameter; LVEDV¼ left ventricle end-diastolic volume; LVEF¼ left ventricular
ejection fraction; LVESV¼ left ventricle end-systolic volume; LVH¼ left ventricular hypertrophy; LVIDd¼ left ventricle end-diastolic diameter; LVIDs¼ left ventricle
end-systolic diameter; LVPW¼ left ventricle posterior wall thickness; RV¼ right ventricle diameter; RWT¼ relative wall thickness; SV¼ stroke volume.
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of HF symptoms
Of all 1,459 participants analyzed, 109 participants suffered from
overt self-reported HF symptoms. Results of univariate and various
multivariate bootstrapping were further listed in Table 3. Increasing
age, female gender, higher BMI, higher systolic blood pressure,
smoking behavior, HTN history, and elevated mass-to-volume ratio
were all strongly associated with HF symptoms (all p< 0.05) in
univariate model, whereas increasing LV mass had borderline statis-
tical signiﬁcance (p¼ 0.062). In multivariate analysis, the indepen-
dency of various baseline characters associated with HF symptoms
was listed in Model 1 (Table 3). Smoking behavior as well as HTN
history was associated with HF symptoms (OR: 2.01 and 1.88;
p¼ 0.028 and 0.031, respectively) in the multivariate adjustment
model with regular exercise status tended to lessen HF symptoms. In
Model2,we furtherassessedthecontributionofLVstructural changes
and geometries in terms of LVmass and RWT in the association of HF
symptoms after adjustment for baseline characters. Higher BMI and
RWT seemed to have a borderline independent value (p¼ 0.087 andFig. 1. The change of cardiac structures in terms of LVESV and LVEDV and systolic function (L
lower limit represented SEM value. Age groups 1¼ age <30; 2¼ age 30e<40; 3¼ age 4
LVEF¼ left ventricular ejection fraction; LVESV¼ left ventricle end-systolic volume; SEM¼0.08, respectively) in the association of HF symptoms, whereas
smoking behavior (OR: 2.14; p¼ 0.013) and regular exercise status
(OR: 0.6;p¼ 0.047) still remained strongly signiﬁcant. InModel 3, the
relative contribution of LV structural geometries in terms of LV mass
and mass-to-volume ratio beyond baseline characters were demon-
strated. In particular, both smoking behavior and LVmass-to-volume
ratio were observed to be signiﬁcantly related to HF symptoms (OR:
2.11 and 2.79; p¼ 0.001 and 0.047, respectively). Higher BMI and
physical inactivity had borderline signiﬁcance (p¼ 0.098 and 0.06,
respectively) in the association of HF symptoms.
4. Discussion
In this study, we demonstrated that changes of cardiac-speciﬁc
structural characters and ventricular geometries were consistently
associated with aging process with ventricular phenotypic
remodeling processes, including increased LV mass or mass index;
RWT and mass-to-volume ratio were found to parallel each other
and were accompanied by more cardiovascular risk factors, such as
HTN, DM, or metabolic abnormalities. Our main objective is toVEF) across ordered age groups of both genders were displayed. Error bar of upper and
0e<50; 4¼ age 50e<60; 5¼ age 60. LVEDV¼ left ventricle end-diastolic volume;
standard error of the mean.
Fig. 2. Various ventricular remodeling geometries across different age groups of both genders were displayed. Regardless of genders, aging process was associated with unfavorable
geometric patterns. Error bar of upper and lower limit represented standard error of the mean value (SEM). Age groups 1¼ age <30; 2¼ age 30e<40; 3¼ age 40e<50; 4¼ age
50e<60; 5¼ age 60. LV¼ left ventricular; RWT¼ relative wall thickness.
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are associated with HF symptoms. Indeed, we proved that altered
ventricular geometries were more likely to develop HF symptoms,
which however, were independent of LV mass and conventional
clinical variables.What is reallyworthnoticing inour study is that the
prevalence of LVHwas not high (nearly 2%) in terms of LVmass index,
suggesting a relatively healthy population in our study. And that
mass-to-volume ratio remained independent after adjusting for LV
mass in the associationwithHF symptoms inour study indicated that
ventricular remodeling per se rather than extent of total ventricular
mass in a relatively healthy populationmay be amore important and
contributable factor for HF symptoms to develop. In our univariate
model, aging itself remained an independent factor of HF symptoms,
whereas this effect was offset in the multivariate models. Possible
reasons may come from the fact that aging is accompanied with
several comorbidities leading to vascular stiffening (such as elevated
blood pressure), which exerts negative impact on cardiac structure
and function in terms of diastolic dysfunction, a recognized index of
ventricular stiffness and an surrogate to subsequent HF develop-
ment22. Variables relating to such comorbidites entered in multivar-
iate model may possibly offset the real impact of aging in our cohort.
As mentioned above, aging as an important contributor to LV
stiffening, diastolic dysfunction, or early-stage ventricular
dysfunction has been well documented7,23,24. Coupled ventricular
and vascular stiffness caused by long-term pressure loadwith aging
or an elevated afterload (HTN) may implicate early-stage HF
symptoms with a relatively preserved EF22,25. Geometric progres-
sion of ventricular remodeling to hypertrophy and the overt
development of HF symptoms from observational studies typicallyillustrated a paradigm26 of such phenotype transition27. Although
EF is relatively preserved, reduced LV midwall shortening function
in patients with LVH has actually been proved28,29 to be related to
worse outcomes30. In line with previous studies, we demonstrated
that aging was associated with phenotypic ventricular remodeling.
Furthermore, we showed that such geometric changes in some
elderly subjects, rather than aging per se or total LV mass, may exert
ventricular functional decay manifested as clinical HF symptoms.
Be that as it may, the link between minor forms of geometric
alterations (such as concentric remodeling), a precursor of hyper-
trophy, and functional deterioration has yet to be established.
In the Multi-Ethnic Study of Atherosclerosis (MESA) study, more
than 5,000 cases without signiﬁcant cardiovascular diseases
were enrolled with magnetic resonance imaging (MRI) data
analyzed31,32. LV geometries and mass measured by MRI method
reveal that increasing age is associated with lower LV volumes,
higher LVEF, lower stroke volumes, markedly higher mass-
to-volume ratio together with reduced myocardial contractility
analyzed by strain deformation. The ﬁnding of a continuously rising
up in LV mass across different age groups in our data may be, to
some extent, more close to that observed by Gardin et al.33 And
thus, it has been hypothesized that in an aging heart accompanied
with mild elevated afterload, the ventricle compensates for
reduced contractility through concentric remodeling with associ-
ated reliance on “cross-ﬁbers” shortening to maintain adequate EF
and wall thickening28,34. In line with the MESA MRI study,31,32 we
did observe a signiﬁcant increase in mass-to-volume ratio and RWT
with aging process and a trend toward higher EF, although
a consistent rise up of LV volumes in the female gender was obvious
Fig. 3. The prevalence and association of diastolic dysfunction with different geometric remodeling patterns from both genders were demonstrated. Worsening remodeling
patterns were related to higher rate of diastolic dysfunction from both genders. LV¼ left ventricular; RWT¼ relative wall thickness.
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our ﬁndings, greater LV volumes associated with age has been
mentioned in some other reports35,36, although substantially
decreasing LV volumes leading to a similar trend of higher mass-
to-volume ratio was observed in the MESA study. Speciﬁcally, our
gender-based difference in the LV volumewas identical to the study
by de Simone et al.37 in which they demonstrated that female
gender had larger LV chamber with aging, whereas this phenom-
enonwas not observed in themale gender. A proportional rise of LV
mass and RWT from both gender with aging, however, was in line
with the community-based study20. Moreover, there was a strong
trend toward increasing prevalence of diastolic dysfunction across
all different worsening remodeling patterns, suggesting the
consistency of such remodeling process related to diastology.
Finally, instead of increasing LV mass in other and our studies, the
MESA reported a relatively unchanged LV mass with age. The major
discrepancies in ﬁndings regarding these aging- and gender-based
ventricular structural changes and geometries may be partially
explained by the different modalities used for volume and mass
analysis. Current advances in the global approach fromMRI data set
may be more realistic while compared with those from traditional
radionuclideventriculography,M-mode, or two-dimensional tracing
by echocardiography. Border detection bias from poor-deﬁnedimaging, varying attenuation, background subtraction errors, or
geometric assumptions are all commonly encountered problems
while using traditional imaging modalities. Although several disad-
vantages may exist, it still holds true that a convenient and bedside
available echocardiogram analysis, as shown by our data, well
identiﬁes the cardiac structural and geometric changeswith age and
help explaining themechanisms underlying HF symptoms in a pop-
ulation free from advanced cardiovascular diseases.
4.1. Limitation
In our study, although we preclude those with overt pulmonary
diseases, including obstructive lung diseases or asthma, to limit
exercise intolerance to those who may really suffer from HF
symptoms, participants with subclinical or those with under-
diagnosed lung disorders may still be enrolled. This may help
explain that smoking behavior itself plays some role in the asso-
ciation of HF symptoms after adjusted for clinical confounders in
our study. Second, the relationship between diastolic dysfunction,
ventricular remodeling, and HF symptoms was not discussed in
detail in this article. Although various detailed quantiﬁcation of
diastolic parameters involved in the clinical application of HF
symptoms with preserved LVEF is of signiﬁcant clinical value,
Table 3
Univariate and various multivariate bootstrapping results
Model Odds
ratio
Bootstrap
SE
Z
Score
p 95% CI
Univariate model
Age 1.03 0.009 2.83 0.005 1.007703e1.043183
Gender (male) 0.58 0.115 2.73 0.006 0.3952658e0.8582324
BMI 1.10 0.027 3.76 <0.001 1.045483e1.151640
SBP 1.01 0.005 2.29 0.022 1.001819e1.023370
Smoking 2.10 0.621 2.67 0.008 1.199477e3.231681
Drinking 1.05 0.245 0.193 0.448 0.7000797e1.656177
Exercise 0.55 0.128 2.55 0.011 0.3512356e0.871666
Uric acid 1.01 0.0677 0.18 0.858 0.8876174e1.153896
HTN Hx 2.52 0.558 4.18 <0.001 1.633209e3.890751
DM Hx 1.51 0.51 1.21 0.227 0.7753865e2.923494
Creatinine 0.791 0.33 0.56 0.574 0.3487174e1.793583
LV mass
(per unit)
1.004 0.0024 1.87 0.062 0.9997838e1.009084
Mass-volume
ratio (per unit)
3.16 0.924 3.94 <0.001 1.783662e5.606039
Multivariate model 1
Age 1.02 0.0138 1.13 0.257 0.9888418e1.042922
Gender (male) 0.62 0.2431 1.21 0.227 0.2912409e1.339354
BMI 1.05 0.036 1.48 0.138 0.9838011e1.125151
SBP 0.99 0.007 0.74 0.459 0.9811147e1.008653
Smoking 2.01 0.6424 2.2 0.028 1.078375e3.763838
Drinking 1.19 0.3757 0.55 0.584 0.6399975e2.20859
Exercise 0.64 0.172 1.64 0.101 0.3815822e1.088804
Uric acid 0.89 0.078 1.37 0.17 0.7465814e1.05301
HTN Hx 1.88 0.549 2.16 0.031 1.059269e3.33277
DM Hx 1.06 0.528 0.13 0.9 0.4026669e2.812795
Creatinine 0.64 0.546 0.52 0.601 0.1203477e3.408464
Multivariate model 2
Age 1.01 0.0132 0.9 0.367 0.9862904e1.038097
Gender (male) 0.6 0.206 1.5 0.134 0.3035676e1.173023
BMI 1.07 0.041 1.71 0.087 0.9904334e1.150741
SBP 1 0.0069 0.51 0.608 0.9830939e1.010021
Smoking 2.14 0.659 2.48 0.013 1.171959e3.703743
Drinking 1.22 0.353 0.7 0.483 0.6955048e2.155069
Exercise 0.6 0.153 1.99 0.047 0.3664911e0.9924333
Uric acid 0.93 0.079 0.79 0.427 0.7918955e1.10383
HTN Hx 1.35 0.398 1.03 0.303 0.760503e2.409459
DM Hx 1.11 0.57 0.2 0.844 0.4032135e3.035786
Creatinine 0.65 0.536 0.52 0.601 0.12884e3.276247
LV Mass
(per unit)
0.99 0.004 0.78 0.433 0.9891782e1.004673
RWT (per 1%) 1.04 0.022 1.78 0.08 0.9960724e1.084129
Multivariate model 3
Age 1.01 0.0134 0.77 0.439 0.9843815e1.036945
Gender (male) 0.6 0.221 1.39 0.166 0.2927143e1.234774
BMI 1.07 0.043 1.66 0.098 0.9879135e1.155878
SBP 1 0.0071 0.49 0.621 0.9825954e1.010546
Smoking 2.11 0.606 2.59 0.01 1.199477e3.703743
Drinking 1.23 0.352 0.72 0.473 0.7000797e2.155757
Exercise 0.61 0.1611 1.88 0.06 0.3611165e1.021353
Uric acid 0.93 0.0819 0.77 0.441 0.7871938e1.109768
HTN Hx 1.35 0.388 1.06 0.29 0.7724509e2.37471
DM Hx 1.11 0.5627 0.2 0.841 0.4092266e2.997889
Creatinine 0.65 0.5474 0.52 0.606 0.1229369e3.39858
LV mass
(per unit)
0.99 0.0047 1.14 0.254 0.9855446e1.003848
Mass-volume
ratio (per unit)
2.79 1.4493 1.97 0.047 1.00706e7.722615
BMI¼ body mass index; CI¼ conﬁdence interval; DM Hx¼ history of diabetes
mellitus; HTN Hx¼ history of hypertension; SBP¼ systolic blood pressure; LV¼ left
ventricular; RWT¼ relative wall thickness; SE¼ standard error.
Aging, Ventricular Remodeling and Heart Failure Symptoms 23previous data suggested that diastolic dysfunction by traditional
assessment may actually parallel cardiac structural changes and
could be dynamic and load dependent38. Third, this study was
actually observational based on a cross-sectional design andmay be
limited by its relatively normal participants with lower incidence of
LVH, which may potentially restrict the generalizability. Whetherthis ventricular remodeling process remains an independent
determinant for future development of overt LV systolic failure or
major cardiovascular events in a longitudinal followupmaywarrant
further studies.
References
1. Redﬁeld MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic
ventricular dysfunction in the community: appreciating the scope of the heart
failure epidemic. JAMA 2003;289:194e202.
2. Bursi F, Weston SA, Redﬁeld MM, et al. Systolic and diastolic heart failure in the
community. JAMA 2006;296:2209e2216.
3. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of
heart failure with preserved ejection fraction. N Engl J Med 2006;355:251e259.
4. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic
insights into cardiovascular performance at rest and during exercise. J Appl
Physiol 2008;105:1342e1351. Epub July 10, 2008.
5. de Simone G, Kitzman DW, Chinali M, et al. Left ventricular concentric geom-
etry is associated with impaired relaxation in hypertension: the HyperGEN
study. Eur Heart J 2005;26:1039e1045.
6. Lam CS, Roger VL, Rodeheffer RJ, et al. Cardiac structure and ventricular-
vascular function in persons with heart failure and preserved ejection fraction
from Olmsted County, Minnesota. Circulation 2007;115:1982e1990.
7. Chen CH, Nakayama M, Nevo E, et al. Coupled systolic-ventricular and vascular
stiffening with age: Implications for pressure regulation and cardiac reserve in
the elderly. J Am Coll Cardiol 1998;32:1221e1227.
8. Klapholz M, Maurer M, Lowe AM, et al, New York Heart Failure Consortium.
Hospitalization for heart failure in the presence of a normal left ventricular
ejection fraction: results of the New York Heart Failure Registry. J Am Coll
Cardiol 2004 Apr 21;43:1432e1438.
9. Abbate A, Scarpa S, Santini D, et al. Myocardial expression of survivin, an
apoptosis inhibitor, in aging and heart failure. An experimental study in the
spontaneously hypertensive rat. Int J Cardiol 2006;111:371e376.
10. Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the
development of congestive heart failure. The Framingham study. N Engl J Med
1972;287:781e787.
11. Kizer JR, Arnett DK, Bella JN, et al. Differences in left ventricular structure
between black and white hypertensive adults: the Hypertension Genetic
Epidemiology Network study. Hypertension 2004;43:1182e1188.
12. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric
patterns in the Framingham Heart Study. J Am Coll Cardiol 1995;25:879e884.
13. Koren MJ, Devereux PB, Casale PN, et al. Relation of left ventricular mass and
geometry to morbidity and mortality in uncomplicated essential hypertension.
Ann Intern Med 1991;114:345e352.
14. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic signiﬁcance of
concentric remodeling of the left ventricle in hypertensive patients with
normal left ventricular mass. J Am Coll Cardiol 1995;25:871e878.
15. Muiesan ML, Salvetti M, Monteduro C, et al. Left ventricular concentric
geometry during treatment adversely affects cardiovascular prognosis in
hypertensive patients. Hypertension 2004;43:731e738.
16. Liu CC, Lo CI, Hung CL, et al. Determinants of left ventricular geometric alter-
ations and related clinical and metabolic factors in a general population.
International Journal of Gerontology 2009;3:66e74.
17. Raizada V, Pathak D, Nakouzi A, et al. Prevention of age-related V1 myosin
isozyme decrement in the adult rat heart. J Mol Cell Cardiol 1994;26:293e296.
18. Lindsey ML, Goshorn DK, Squires CE, et al. Age-dependent changes in
myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase
proﬁles and ﬁbroblast function. Cardiovasc Res 2005;66:410e419.
19. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left
ventricular mass in a healthy population (the Framingham Study). Am J Cardiol
1989;64:1066e1068.
20. RedﬁeldMM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-
vascular stiffening: a community-basedstudy.Circulation2005;112:2254e2262.
21. Lang RM, Bierig M, Devereux RB, et al, Chamber Quantiﬁcation Writing Group,
American Society of Echocardiography’s Guidelines and Standards Committee,
European Association of Echocardiography. Recommendations for chamber
quantiﬁcation: a report from the American Society of Echocardiography’s
Guidelines and Standards Committee and the Chamber Quantiﬁcation Writing
Group, developed in conjunction with the European Association of Echocar-
diography, a branch of the European Society of Cardiology. J Am Soc Echo-
cardiogr 2005;18:1440e1463.
22. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology.
Hypertension 2005;46:185e193.
23. Templeton GH, Platt MR,Willerson JT, et al. Inﬂuence of aging on left ventricular
hemodynamics and stiffness in beagles. Circ Res. 1979 Feb;44:189e194.
24. Lieber SC, Aubry N, Pain J, et al. Aging increases stiffness of cardiac myocytes
measured by atomic force microscopy nanoindentation. Am J Physiol Heart Circ
Physiol 2004;287:H645eH651.
25. Borlaug BA, Lam CS, Roger VL, et al. Contractility and ventricular systolic
stiffening in hypertensive heart disease: insights into the pathogenesis of heart
failure with preserved ejection fraction. J Am Coll Cardiol 2009;54:410e418.
26. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J
Med 1992;327:998e1008.
C.-L. Hung et al.2427. Wright JW, Mizutani S, Harding JW. Pathways involved in the transition from
hypertension to hypertrophy to heart failure. Treatment strategies. Heart Fail
Rev 2008;13:367e375.
28. Aurigemma GP, Silver KH, Priest MA, et al. Geometric changes allow normal
ejection fraction despite depressed myocardial shortening in hypertensive left
ventricular hypertrophy. J Am Coll Cardiol 1995;26:195e202.
29. Shimizu G, Hirota Y, Kita Y, et al. Left ventricular midwall mechanics in
systemic arterial hypertension. Myocardial function is depressed in pressure-
overload hypertrophy. Circulation 1991;83:1676e1684.
30. de Simone G, Devereux RB, Koren MJ, et al. Midwall left ventricular mechanics.
An independent predictor of cardiovascular risk in arterial hypertension.
Circulation 1996;93:259e265.
31. Rosen BD, Edvardsen T, Lai S, et al. Left ventricular concentric remodeling is
associated with decreased global and regional systolic function: the Multi-
Ethnic Study of Atherosclerosis. Circulation 2005;112:984e991.
32. Cheng S, Fernandes VRS, Bluemke DA, et al. Age-related left ventricular
remodeling and associated risk for cardiovascular outcomes: The Multi-Ethnic
Study of Atherosclerosis. Circ Cardiovasc Imaging 2009;2:191e198.33. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age, and disease affect
echocardiographic left ventricular mass and systolic function in the free-living
elderly: The Cardiovascular Health Study. Circulation 1995;91:1739e1748.
34. de Simone G, Ganau A, Roman MJ, et al. Relation of left ventricular longitudinal
and circumferential shortening to ejection fraction in the presence or in the
absence of mild hypertension. J Hypertens 1997;15:1011e1017.
35. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is
maintained with advancing age in healthy human subjects: cardiac dilatation
and increased stroke volume compensate for a diminished heart rate. Circu-
lation 1984;69:203e213.
36. Nussbacher A, Gerstenblith G, O’Connor FC, et al. Hemodynamic effects of
unloading the old heart. Am J Physiol Heart Circ Physiol 1999;277:H1863eH1871.
37. de Simone G, Devereux RB, Roman MJ, et al. Gender differences in left
ventricular anatomy, blood viscosity and volume regulatory hormones in
normal adults. Am J Cardiol 1991;15:1704e1708.
38. Wachtell K, Smith G, Gerdts E, et al. Left ventricular ﬁlling patterns in patients
with systemic hypertension and left ventricular hypertrophy (the LIFE study).
Losartan Intervention For Endpoint. Am J Cardiol 2000;85:466e472.
